This gene is largely responsible for the production of anti–acetylcholine receptor antibodies in patients with myasthenia gravis, thus inhibiting the proliferation and IFN-γ production of those cells and reducing the severity of the condition (Jambou et al., 2003). This evidence concerns the gene IFNG and myasthenia gravis.